Low Dose-Averaged Linear Energy Transfer Contributes to Local Recurrence of Pancreatic Cancer Treated With Carbon Ion Radiation Therapy.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
106 patients.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] This is the largest study investigating the association between tumor LET profiles and LC post-CIRT. The results suggest that low LET within the CTV is associated with poor LC in patients with pancreatic cancer treated with CIRT.
[PURPOSE] To evaluate the effects of dose-averaged linear energy transfer (LET) profiles on local control (LC) of pancreatic cancer treated with carbon ion radiation therapy (CIRT).
- p-value P = .023
- p-value P = .020
- 95% CI 0.71-0.98
APA
Sakamoto S, Oike T, et al. (2025). Low Dose-Averaged Linear Energy Transfer Contributes to Local Recurrence of Pancreatic Cancer Treated With Carbon Ion Radiation Therapy.. International journal of radiation oncology, biology, physics, 123(4), 1071-1079. https://doi.org/10.1016/j.ijrobp.2025.07.1406
MLA
Sakamoto S, et al.. "Low Dose-Averaged Linear Energy Transfer Contributes to Local Recurrence of Pancreatic Cancer Treated With Carbon Ion Radiation Therapy.." International journal of radiation oncology, biology, physics, vol. 123, no. 4, 2025, pp. 1071-1079.
PMID
40681056 ↗
Abstract 한글 요약
[PURPOSE] To evaluate the effects of dose-averaged linear energy transfer (LET) profiles on local control (LC) of pancreatic cancer treated with carbon ion radiation therapy (CIRT).
[METHODS AND MATERIALS] Data from patients with inoperable pancreatic cancer, treated with CIRT and concurrent chemotherapy between 2013 and 2021, were analyzed retrospectively. The prescribed dose was 55.2 Gy (relative biological effectiveness), administered in 12 fractions. The LET of CIRT plans were calculated using a previously reported in-house pipeline. The association between tumor LET profiles and local recurrence (LR) was analyzed.
[RESULTS] The study analyzed 106 patients. The 2-year cumulative LR rate was 20.2% (95% confidence interval [CI], 12.8%-28.9%). Analysis of LET parameters using a Fine-Gray regression model showed that the minimum LET (L) for the clinical target volume (CTV) had a significant effect on LR (P = .023). According to the cut-off value of 42.2 keV/µm, determined by time-dependent receiver operating characteristic analysis at 18 months, patients with low CTV L had a significantly greater cumulative LR rate than those with high CTV L (P = .020; 2-year cumulative LR rate, 32.4% [95% CI, 16.6%-49.3%] vs 12.7% [95% CI, 5.8%-22.5%]). Cause-specific proportional hazards models identified CTV L as a significant predictor of LR (hazard ratio, 0.83; [95% CI, 0.71-0.98]; P = .030). CTV L showed a strong, significant negative correlation with CTV (P < .0001, r = -0.52).
[CONCLUSIONS] This is the largest study investigating the association between tumor LET profiles and LC post-CIRT. The results suggest that low LET within the CTV is associated with poor LC in patients with pancreatic cancer treated with CIRT.
[METHODS AND MATERIALS] Data from patients with inoperable pancreatic cancer, treated with CIRT and concurrent chemotherapy between 2013 and 2021, were analyzed retrospectively. The prescribed dose was 55.2 Gy (relative biological effectiveness), administered in 12 fractions. The LET of CIRT plans were calculated using a previously reported in-house pipeline. The association between tumor LET profiles and local recurrence (LR) was analyzed.
[RESULTS] The study analyzed 106 patients. The 2-year cumulative LR rate was 20.2% (95% confidence interval [CI], 12.8%-28.9%). Analysis of LET parameters using a Fine-Gray regression model showed that the minimum LET (L) for the clinical target volume (CTV) had a significant effect on LR (P = .023). According to the cut-off value of 42.2 keV/µm, determined by time-dependent receiver operating characteristic analysis at 18 months, patients with low CTV L had a significantly greater cumulative LR rate than those with high CTV L (P = .020; 2-year cumulative LR rate, 32.4% [95% CI, 16.6%-49.3%] vs 12.7% [95% CI, 5.8%-22.5%]). Cause-specific proportional hazards models identified CTV L as a significant predictor of LR (hazard ratio, 0.83; [95% CI, 0.71-0.98]; P = .030). CTV L showed a strong, significant negative correlation with CTV (P < .0001, r = -0.52).
[CONCLUSIONS] This is the largest study investigating the association between tumor LET profiles and LC post-CIRT. The results suggest that low LET within the CTV is associated with poor LC in patients with pancreatic cancer treated with CIRT.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.